Company Overview

Development Stage

About the Company

[Summary] 从事创新药物、高端仿制药的研发及产业化的创新型医药企业

海融医药,一家坚持创新驱动和研发产品差异化竞争策略的制药企业,拥有*的活性维生素D衍生物类药物研发技术、多条创新药及改良型新药研发管线,致力于为患者提供更好的治疗药物,让生命更有价值。
海融医药以临床、患者的需求为导向,专注于镇痛、皮肤科、骨科、肾科与抗感染五个治疗领域的创新药、改良型新药与高端仿制药自主研发,开展细胞治疗药物联合研发,构建具有海融特色的研发技术平台与丰富的研发管线。
目前,海融医药拥有30余个处于不同阶段的研发管线,其中创新药与改良型新药占比超过一半以上。企业成立九年来,已有10余个项目获得生产批件与临床批件,其中海芙润®他卡西醇软膏为治疗银屑病的一线推荐药物,瑞加诺生注射液为临床诊断心肌缺血的亟需药物,应用于镇痛领域的创新药项目HR1405-01项目可以有效降低阿片类成瘾性药的临床使用。未来2-3年,海融医药还将获得5-6个生产批件与2-3个临床批件。截止目前,企业已申请专利107项,授权50项,PCT专利8项。
围绕期待更高、更广泛的生命健康与社会需求,以自身的专业与技术履行社会责任,海融医药正在凝聚更加多元化的资源,通过控股公司南京锐志生物医药有限公司开展抗感染药物、多肽类药物的研发与技术服务,南京灿辰微生物科技有限公司拓展微生物检测、挑战与相关微生物、致病菌的控制与治理,海勃(上海)医药科技有限公司致力于把优质的原料药、辅料在人用与动物药品制造领域内进行国际间的推广与贸易。
招聘联系人:***联系方式:***********(微信同号)
简历投递邮箱:hr@*
公司微信公众号:海融医药/海融招聘,敬请关注,了解更多资讯。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

海融医药 Financing History (1 rounds)

Manage
新三板
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 新三板
  • Deal: 全国股转系统

海融医药 How Fast Is Hiring Growing? (23 open positions)

Manage
Note: How fast is hiring at 南京海融医药科技股份有限公司 growing? 海融医药2025: 65 openings (up 8%), 2024: 60 openings (up 2%), 2023: 59 openings (up 211%), 2022: 19 openings (down 82%), 2021: 103 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

海融医药 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 40%
  • 2024: Flat 0%-
  • 2023: Flat 0%-
  • 2022: Down 44%
海融医药 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 南京海融医药科技股份有限公司 growing? 海融医药Master's recruitment over the years: 2025: 3 openings (down 40%), 2024: 5 openings (flat), 2023: 5 openings (flat), 2022: 5 openings (down 44%), 2021: 9 openings.

海融医药 — What Are the Salaries Like? (48 records)

Manage
海融医药 Salary Overview
salary range: 2K - 50K, 58.3% of roles pay ¥10-20K
Note: salary statistics are based on 48 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 南京海融医药科技股份有限公司?海融医药58.3% of positions earn 10-20K, Undergraduate salary: ¥。Nanjing salary ranking: #869,销售类 average salary ¥16.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 海融医药

(More)
Are salaries high at 南京海融医药科技股份有限公司? We provide: otc经理,零售,产品专员,产品经理,培训,市场,操作工,财务,分析,实习生,工艺技术,招商,qc,合成生物学,工程项目,护工,档案管理,检测,检验,维修工. Click to view detailed salary analysis by job.

海融医药 honors, qualifications & industry associations

海融医药 Related Industry Tags

Job Category

  • 销售类
    35.4% of total 35.4%
  • 技工类
    16.7% of total 16.7%
  • 生物/制药/化工/环保类
    16.7% of total 16.7%
  • 商业零售类
    14.6% of total 14.6%

Education

  • 大专
    52.1% of total 52.1%
  • 本科
    35.4% of total 35.4%
  • 高中
    6.3% of total 6.3%
  • 硕士
    6.3% of total 6.3%

Experience

  • 3-5年
    50% of total 50%
  • 不限
    22.9% of total 22.9%
  • 1-3年
    18.8% of total 18.8%
  • 5-10年
    8.3% of total 8.3%
View Detailed Analysis

What does 南京海融医药科技股份有限公司 require? Who is 海融医药 hiring? 海融医药 recruitment: 销售类占比最多占35.4%,其次是技工类占16.7%. What education can get in at 海融医药? 大专占比最多占52.1%,其次是本科占35.4%. High education required at 海融医药? 硕士占6.3%. Work experience required at 海融医药? 3-5年占比最多占50%,其次是不限占22.9%. Where are the job locations at 海融医药? 南京占比最多占68.8%,其次是重庆占8.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 5,552.3565万(元)
Legal Representative: 晁阳
Date Established:
Credit Code: 91320115062615801H
Registered Address: 南京市江宁区龙眠大道568号生命科技小镇北区10号楼

Partners & Suppliers

供应中间体产品 Source
合作客户 医药中间体/粗品供应
与南京大学共建联合实验室,开展活性维生素D类药物相关基础研究。 Source
供应商 高校/研究院合作

People who follow 海融医药 also follow

海融医药 Competitors (Similar Companies)

“Helping patients access more effective medicines sooner”
“A renowned enterprise in China's liver disease and anti-tumor fields”
软膏剂 医药工业 原料药 制药/药业
医药 生物科技/生物工程 医药工业 动物健康
生物科技/生物工程 医药 基因合成 生物医药
“Core member enterprise of China National Machinery Industry Corporatio”
新材料 化工/化学 工程材料 聚醚
晶圆代工 半导体 积体电路制造 生产
“致力于成为的生命科学服务整体解决方案品牌供应商”
“Manufacturing "biochips" to provide source power for the development o”
制药/药业 维生素 新药研发 生物科技/生物工程
“Research, development, and production of anti-tumor and surgical medic”
制药/药业 医药 药物研发 中药研发
外墙外保温 保温材料 防火板 岩棉板
合成橡胶 丙烯 石油 化工/化学

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates